Conclusions Ischemic stroke triggers a coordinated metabolic crisis characterized by ATP depletion, mitochondrial dysfunction, excitotoxicity, oxidative and nitrosative stress, maladaptive glycolysis, lactate and pH dysregulation, NAD + /FAD imbalance, inflammatory immunometabolism, endothelial-pericyte uncoupling, and impaired neurovascular repair
A Word of Caution Always consult your healthcare provider before starting semaglutide
A recent analysis from Aon provides some promising data points to support this hypothesis
Clinical trial results overview Phase 2 trial outcomes: Eli Lilly's phase 2 trials demonstrated dose-dependent weight loss reaching 24.2% at the highest doses over 48 weeks
Your provider decides the strength, how often to use it, and whether it makes sense for your skin
Lets take a look at some studies that looked at if breast milk is affected by semaglutide: LactMed (Dec 2024): No semaglutide detected in breast milk samples from mothers on injectable forms